Revenue

The natural gas producer raised its quarterly dividend by 11%, backed by strong earnings and a positive outlook despite volatile energy prices.

As Summit Midstream sets its Q4 earnings date, all eyes are on whether recent acquisitions and strong gas trends can solidify its financial recovery.

The organ transplant innovator's massive Q4 profit came from a tax rule, but it signals a major turning point and confidence in long-term profitability.

A key European panel recommends Dupixent for children with chronic hives, offering a potential first-of-its-kind targeted therapy for a difficult condition.

The waste giant is renewing its massive share repurchase program and adding a special tool to help its biggest institutional investors cash out.

Fulgent Genetics reports revenue growth but faces a pivotal year with a major customer loss, betting its future on strategic acquisitions and a promising drug pipeline.

The consumer intelligence giant posts blockbuster results, achieves positive cash flow, and unveils a new AI-driven strategy for sustained market leadership.

MedX Health Corp. lands a crucial $2.7M in initial funding, aiming for $5M to expand its skin-screening tech into occupational health and manage debt.

Following mixed 2025 results, TransAlta will outline its strategic pivot to investors, focusing on renewables, data centers, and shareholder value.

Gogo's revenue doubled to $910M in 2025 after a major acquisition, but a Q4 loss and new tech rollout put its bold global strategy to the test.

A new AI-powered digital twin, backed by US government funding, promises to predict network failures and slash deployment costs for 5G/6G networks.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

As BCE's CEO prepares for a key investor conference, the telecom giant balances a bold AI growth strategy against concerns over near-term profitability.

Endeavour Silver saw record 2025 revenue from new mines but posted a $119M loss due to financial instruments, high costs, and rising security risks in Mexico.

Startup World Cup's 'East Meets West' event positions Hawaii as a crucial hub for cross-Pacific innovation, with a $1M prize and Tim Draper in attendance.

New platform Xmarket challenges rivals by sharing revenue with creators, introducing a new model to invest in a market's success, not just its outcome.

Natural Resource Partners reports robust cash flow and near-zero debt, but severe headwinds in coal and soda ash markets test its long-term strategy.

A new oral therapy, mavorixafor, receives a key recommendation in Europe, offering a beacon of hope for patients with a debilitating ultra-rare immune disorder.

At a UN event, Beijing launched a book on its governance model and promoted its Global Governance Initiative, signaling a push to reshape international order.

Graphite One's new tradable warrants aim to fund a vital domestic graphite project, but investors face a long road from financial maneuver to production.